Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2112-2114
doi: 10.1161/01.STR.0000023491.63693.18
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schäbitz, W.-R.
Right arrow Articles by Piomelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäbitz, W.-R.
Right arrow Articles by Piomelli, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUTAMIC ACID HYDROCHLORIDE
*GLYCERIN
*LACTIC ACID
*OLEIC ACID
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Acute Stroke Syndromes
Right arrow Other Stroke Treatment - Medical
Right arrow Lipid and lipoprotein metabolism

(Stroke. 2002;33:2112.)
© 2002 American Heart Association, Inc.


Case Report

Release of Fatty Acid Amides in a Patient With Hemispheric Stroke

A Microdialysis Study

Wolf-R. Schäbitz, MD; Andrea Giuffrida, PhD; Christian Berger, MD; Alfred Aschoff, MD; Markus Schwaninger, MD; Stefan Schwab, MD Daniele Piomelli, PhD

From the Departments of Neurology (W-R.S., C.B., M.S., S.S.) and Neurosurgery (A.A.), University of Heidelberg, Heidelberg, Germany, and Department of Pharmacology, University of California at Irvine (A.G., D.P.).

Correspondence to Stefan Schwab, MD, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.

Background Excitotoxic insults such as stroke may induce release of fatty acid ethanolamides (FAEs), contributing to the downstream events in the ischemic cascade. We therefore studied release of FAEs such as anandamide, palmitylethanolamide (PEA), and oleylethanolamide (OEA) in the brain of a patient suffering from malignant hemispheric infarction treated with hypothermia.

Case Description A patient with life-threatening hemispheric stroke was treated with moderate hypothermia (33°C) that was maintained for 3 days, followed by a 3-day rewarming period. Microdialysis was applied to measure glutamate, lactate, and glycerol by using a microdialysis analyzer. FAEs were measured by microdialysis coupled with high-performance liquid chromatography/mass spectrometry. Release of neuroprotective fatty amides occurred within the first day after ischemia and reached high concentrations for all 3 substances in tissue surrounding the primary ischemic lesion: anandamide up to 42 pmol/mL, PEA up to 120 pmol/mL, and OEA up to 242 pmol/mL. There was a significant correlation with elevation of lactate as early marker for the hypoxic insult.

Conclusions This is the first report demonstrating release of FAEs in vivo during human stroke and may suggest contribution of the FAE signaling system to the pathophysiological events after ischemia.


Key Words: amides • cannabinoids • cerebral ischemia • fatty acids • microdialysis • stroke




This article has been cited by other articles:


Home page
IOVSHome page
Y. F. Njie, Z. Qiao, Z. Xiao, W. Wang, and Z.-H. Song
N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4528 - 4534.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Rajesh, H. Pan, P. Mukhopadhyay, S. Batkai, D. Osei-Hyiaman, G. Hasko, L. Liaudet, B. Gao, and P. Pacher
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
J. Leukoc. Biol., December 1, 2007; 82(6): 1382 - 1389.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, et al.
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
FASEB J, June 1, 2007; 21(8): 1788 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Benito, W.-K. Kim, I. Chavarria, C. J. Hillard, K. Mackie, R. M. Tolon, K. Williams, and J. Romero
A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis
J. Neurosci., March 9, 2005; 25(10): 2530 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Patel, E. J. Carrier, W-S. V. Ho, D. J. Rademacher, S. Cunningham, D. S. Reddy, J. R. Falck, B. F. Cravatt, and C. J. Hillard
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity
J. Lipid Res., February 1, 2005; 46(2): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella
Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility
J. Neurosci., August 27, 2003; 23(21): 7767 - 7775.
[Abstract] [Full Text] [PDF]